Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 3
1980 3
1981 6
1982 4
1983 8
1984 10
1985 12
1986 10
1987 7
1988 23
1989 22
1990 31
1991 44
1992 42
1993 54
1994 51
1995 55
1996 60
1997 73
1998 73
1999 75
2000 103
2001 116
2002 167
2003 186
2004 263
2005 363
2006 438
2007 496
2008 554
2009 647
2010 741
2011 908
2012 1082
2013 1278
2014 1564
2015 1749
2016 1770
2017 2099
2018 2424
2019 2841
2020 3589
2021 4213
2022 5162
2023 725
Text availability
Article attribute
Article type
Publication date

Search Results

30,483 results
Results by year
Filters applied: . Clear all
Page 1
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators. Goyal L, et al. Among authors: he y. N Engl J Med. 2023 Jan 19;388(3):228-239. doi: 10.1056/NEJMoa2206834. N Engl J Med. 2023. PMID: 36652354 Clinical Trial.
Editorial: Immunotherapy for NSCLC with oncogenic driver variants.
Du Y, Chu Q, Lou Y, He Y, Hu H, Hu Q, Huang M. Du Y, et al. Among authors: he y. Front Oncol. 2022 Dec 8;12:1095947. doi: 10.3389/fonc.2022.1095947. eCollection 2022. Front Oncol. 2022. PMID: 36568249 Free PMC article. No abstract available.
Editorial: Host cellular responses to viruses.
He Y, Li Y, Cao Y, Liu J. He Y, et al. Front Microbiol. 2023 Jan 10;14:1110197. doi: 10.3389/fmicb.2023.1110197. eCollection 2023. Front Microbiol. 2023. PMID: 36704612 Free PMC article. No abstract available.
Ferroptosis: Reviewing CRC with the Third Eye.
Liu X, Tuerxun H, Li Y, Li Y, He Y, Zhao Y. Liu X, et al. Among authors: he y. J Inflamm Res. 2022 Dec 21;15:6801-6812. doi: 10.2147/JIR.S389290. eCollection 2022. J Inflamm Res. 2022. PMID: 36575747 Free PMC article. Review.
Toward memristive in-memory computing: principles and applications.
Bao H, Zhou H, Li J, Pei H, Tian J, Yang L, Ren S, Tong S, Li Y, He Y, Chen J, Cai Y, Wu H, Liu Q, Wan Q, Miao X. Bao H, et al. Among authors: he y. Front Optoelectron. 2022 May 12;15(1):23. doi: 10.1007/s12200-022-00025-4. Front Optoelectron. 2022. PMID: 36637566 Free PMC article. Review.
Emerging Nanoagents for Medical X-ray Imaging.
Wu Q, Zheng Q, He Y, Chen Q, Yang H. Wu Q, et al. Among authors: he y. Anal Chem. 2023 Jan 10;95(1):33-48. doi: 10.1021/acs.analchem.2c04602. Anal Chem. 2023. PMID: 36625104 Review. No abstract available.
Exosomes treating osteoarthritis: hope with challenge.
Wu C, He Y, Yao Y, Yang H, Lu F. Wu C, et al. Among authors: he y. Heliyon. 2023 Jan 21;9(1):e13152. doi: 10.1016/j.heliyon.2023.e13152. eCollection 2023 Jan. Heliyon. 2023. PMID: 36711315 Free PMC article. Review.
Clinical guidelines for microwave ablation of spinal metastases.
Yang T, Ke J, Cheng S, He Y, Huang W, Yao M, Zhou J, Zhong G, Hu Y, Zhang Y. Yang T, et al. Among authors: he y. J Cancer Res Ther. 2022 Dec;18(7):1845-1854. doi: 10.4103/jcrt.jcrt_655_22. J Cancer Res Ther. 2022. PMID: 36647941 Free article. Review.
30,483 results
You have reached the last available page of results. Please see the User Guide for more information.